Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck CancerEben L. Rosenthal, Kurt R. Zinn, Cecelia E. Schmalbach et al.|Clinical Cancer Research|2015Cited by 477
Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck CancerEben L. Rosenthal, Jason M. Warram, Kurt R. Zinn et al.|Clinical Cancer Research|2017Cited by 152
In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell CarcinomasEsther de Boer, Margaret Brandwein‐Gensler, Thomas K. Chung et al.|Scientific Reports|2015Cited by 101